• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

RadNet says it intends to acquire Truxtun, Health Diagnostics

Article

Los Angeles-based firm RadNet announced on March 15 it entered into letters of intent to acquire Truxtun Radiology Medical Group and the New Jersey operating subsidiary of Health Diagnostics.

Los Angeles-based firm RadNet announced on March 15 it entered into letters of intent to acquire Truxtun Radiology Medical Group and the New Jersey operating subsidiary of Health Diagnostics. Health Diagnostics has four locations in New Jersey: Edison, Freehold, Green Brook, and Old Bridge.

In their quarterly report, RadNet says it expects the cash consideration for the acquisitions will be approximately $24.5 million, plus 375,000 shares of common stock.

On the day of the announcement RadNet’s stock price closed 19 cents higher at $3 per share.

The acquisitions are not the only ones this year. On Jan. 1 RadNet acquired Union Imaging Center in N.J.

“All three acquisitions are of high quality multi-modality operators, which will strengthen our presence and competitive position in existing core markets of RadNet,” Dr. Howard Berger, RadNet’s chairman and CEO, said in the earnings release.

RadNet, founded in 1980, has approximately 4000 employees and operates in seven states: California, Maryland, Delaware, New Jersey, New York, Florida, and Kansas. RadNet. It has a network of 175 owned and operated outpatient imaging centers.

Dr. Girish Patel, who founded Bakersfield, CA-based Truxtun Radiology Medical Group, will remain as medical director of Truxtun for five years.

“This offer gave him the opportunity to plan for his eventual exit without leaving the business he founded 27 years ago, and with the assurance the business will continue even after he retires,” said Chip Robinson, chief operating officer of Truxtun.

The sale is expected to close sometime in April.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.